Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

March 7, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Is Covid-19 being partial towards certain blood groups

DBT-Research Associateship in Biotech & Life Sciences 2020 | Official Notification

CSIR Exam Dates Rescheduled !

Is Covid-19 being partial towards certain blood groups
  • BiotechToday
  • World

Is Covid-19 being partial towards certain blood groups

bioxone October 16, 2020October 16, 2020

Ayooshi Mitra, Amity University Kolkata

Study claims that individuals with blood type O are less inclined to get affected by the novel Coronavirus. For such blood type, developing symptoms like organ failures are also low. Nevertheless, individuals with blood groups A and AB are more susceptible to procuring this infection. There have been several studies conducted on SARS-CoV-1 that have put forward the information that a protective effect of anti-A antibodies against the entry of viral cells may be important for the SARS-CoV-2 infection. Therefore this study was piloted to understand whether there were associations of the ABO blood groups, with different extremities of COVID-19.

The data collected was based on a number of factors. Through the study, it was found that ABO blood groups exhibited different risks of association for the infection. However, the distribution of ABO blood groups showed no sex and age predilections. Unambiguously, blood group A was seen to be associated with a higher risk whereas blood group O was associated with a lower risk, thus indicating that the ABO blood type may be a biomarker for differential susceptibility of COVID-19. Similar results were obtained in studies conducted in China (Zhao, Jiao, et al., 2020) and Hong Kong (Cheng, Yufeng, et al., 2005).

This study, conducted by Hoiland, R., et al., 2020 has been published in the journal “Blood Advances” .

Also read: Can a plant produce anti-SARS-CoV-2 antibody?

References: 

  • Ryan L. Hoiland, Nicholas A. Fergusson, Anish R. Mitra, Donald E. G. Griesdale, Dana V. Devine, Sophie Stukas, Jennifer Cooper, Sonny Thiara, Denise Foster, Luke Y. C. Chen, Agnes Y. Y. Lee, Edward M. Conway, Cheryl L. Wellington, Mypinder S. Sekhon; The association of ABO blood group with indices of disease severity and multiorgan dysfunction in COVID-19. Blood Adv 2020; 4 (20): 4981–4989. doi: https://doi.org/10.1182/bloodadvances.2020002623

  1. Zhao, Jiao, et al. “Relationship between the ABO Blood Group and the COVID-19 Susceptibility.” medRxiv (2020).

Link for article: https://www.medrxiv.org/content/medrxiv/early/2020/03/27/2020.03.11.20031096.full.pdf

  1. Cheng, Yufeng, et al. “ABO blood group and susceptibility to severe acute respiratory syndrome.” Jama 293.12 (2005): 1447-1451.

Link for article: https://jamanetwork.com/journals/jama/article-abstract/200582

  • https://www.thehindubusinessline.com/news/science/blood-type-o-least-vulnerable-to-covid-a-and-ab-at-most-risk-study/article32859423.ece
  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP
  • AI Literacy in Early Childhood Education: Challenges and Opportunities

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged ABO blood group association blood type chart China coronavirus china coronavirus update COVID-19 hong kong infection SARS-CoV-2 susceptible

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • Examinations
  • Signaling Pathway

CSIR Exam Dates Rescheduled !

bioxone October 16, 2020

Keeping in view the academic interest of a large number of students/candidates, the Ministry of Home Affairs(MHA) has agreed to the proposal of MHRD ( now MoE) for conducting various Entrance (and other) Examinations.  Accordingly, in modification of dates announced earlier and in consultation with Council of Scientific & Industrial Research (CSIR), the National Testing […]

CSIR

Related Post

  • BiotechToday
  • World

Alzheimer’s-like dementia due to Covid

BioTech Today June 17, 2021June 16, 2021

Souradip Mallick, National Institute of Technology, Rourkela In the last two decades, various coronavirus diseases have become a major public health issue, starting with the SARS-CoV pandemic in 2002 through 2003, then the Middle East respiratory syndrome coronavirus (MERS-CoV) epidemic in 2012, and current the COVID-19 pandemic. In all the cases, it has been reported […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Shionogi is in a race against Pfizer and Merck

BioTech Today August 4, 2021August 4, 2021

Sneha Singhal, Jaypee Institute of information technology, Noida Pfizer Inc. and Merck & Co. in the race to find treatments for Covid-19 have joined a Japanese company in starting human trials for the first once-daily pill. Shionogi and Co., of Osaka, claimed that its pill would neutralize the Coronavirus in five days or less. The […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Gene therapy clinical trials for rare Angelman syndrome put on hold

bioxone November 7, 2020November 6, 2020

Surupa Chakraborty, Amity University Kolkata A new gene therapy clinical trial for treating Angelman syndrome has been put to hold after two candidates temporarily lost their ability to walk. GTX102, the drug used in the clinical trial was developed by a California-based biopharmaceutical company Ultragenyx, in collaboration with GeneTx, a Florida-based biotech startup. The trial […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy